Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01315236
Show Display Options
Rank Status Study
1 Recruiting Arikace® for Nontuberculous Mycobacteria
Condition: Pulmonary Nontuberculous Mycobacterial Lung Disease
Interventions: Drug: Liposomal amikacin for inhalation;   Drug: placebo

Indicates status has not been verified in more than two years